首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Multicenter safety and efficacy analysis of assisted closure after antegrade arterial punctures using the StarClose device.
【24h】

Multicenter safety and efficacy analysis of assisted closure after antegrade arterial punctures using the StarClose device.

机译:使用StarClose设备进行顺行动脉穿刺后辅助闭合的多中心安全性和疗效分析。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the safety and efficacy of the StarClose device for closure of antegrade punctures following infrainguinal endovascular interventions. METHODS: A retrospective review was conducted of 221 consecutive patients treated with the StarClose device in a 12-month period at 5 centers (4 French and 1 British). Of these, 107 patients (69 men; median age 75 years, range 44-93) were from the UK cohort (111 closures), and 94 patients (75 men; median age 67 years, range 32-95) were from the French cohort (111 closures). Technical success, complication rates, demographic data, medical history, and procedural details were gathered for all patients. Residual bleeding and the requirement for additional manual compression were recorded when the device failed. Clinical evaluation was performed at discharge; color-coded duplex ultrasonography was done in a subset of French patients. RESULTS: The overall technical success rate was 94.6% (210/222; 95% CI 3.1%-9.2%). The results were similar in the 2 cohorts: 95.5% (106/111; 95% CI 1.9%-10.1%) in the UK and 93.7% (104/111; 95% CI 3.1%-12.4%) in France. The 12 failures (5 UK and 7 France) were due to several mechanisms: device failure (n=5), obesity (n=1), groin scarring (n=2), and unexplained (n=4). In 2 failed cases, open surgical closure of the arteriotomy was performed because pressure hemostasis failed. Two pseudoaneurysms were observed: one after immediate failure was successfully treated by prolonged pressure; the other, after apparent success of the device, required surgical therapy. The incidence of serious vascular complication was 1.8% (4/222; 95% CI 0.7%-4.5%); 2 patients from each cohort. CONCLUSION: The StarClose device safely and effectively closes antegrade punctures after infrainguinal endovascular intervention, even in patients who would be considered to be at high risk for puncture-site bleeding. However, a randomized trial would be required to support any definitive recommendations.
机译:目的:评估在肛门下血管内介入治疗后,StarClose装置用于闭合顺行性穿刺的安全性和有效性。方法:回顾性回顾了12个连续月在5个中心(4个法国和1个英国)接受StarClose装置治疗的221例患者。其中107例患者(69名男性;中位年龄75岁,范围44-93)来自英国队列(111名闭塞患者); 94例患者(75名男性;中位年龄67岁,范围32-95)来自法国人群。队列(111个关闭)。收集了所有患者的技术成功率,并发症发生率,人口统计学数据,病史和手术细节。当设备发生故障时,会记录残留的出血和需要进行额外手动按压的情况。出院时进行临床评估;在部分法国患者中进行了彩色双工超声检查。结果:总体技术成功率为94.6%(210/222; 95%CI 3.1%-9.2%)。在这两个队列中,结果相似:英国为95.5%(106/111; 95%CI 1.9%-10.1%),法国为93.7%(104/111; 95%CI 3.1%-12.4%)。 12个故障(5个英国和7个法国)是由于以下几种原因造成的:设备故障(n = 5),肥胖症(n = 1),腹股沟疤痕(n = 2)和无法解释的故障(n = 4)。在2例失败的病例中,由于压力止血失败,进行了开放式外科手术,进行了动脉切开术。观察到两种假性动脉瘤:一种是在长期失败后立即通过长时间加压成功治疗的;另一种是动脉瘤。另一种方法是,在设备明显成功后,需要进行手术治疗。严重血管并发症的发生率为1.8%(4/222; 95%CI 0.7%-4.5%);每个队列2名患者。结论:即使在被认为极有可能发生穿刺部位出血的患者中,在进行腔内腔内介入后,StarClose设备仍可安全有效地关闭顺行穿刺。但是,将需要进行随机试验以支持任何明确的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号